Article image
Article image

MAN AGAINST MOSQUITO MALARIA HAS KILLED more men than wars have ever done. Its conquests in days gone by have played a large part in determining the pattern of civilisation. Prior to 1925, the only antimalarial in general use was quinine. In that year the synthetic compound pamaquin was introduced, to be followed mepacrine in 1930 In 1944, Paludrine was discovered in the IC I research kaboratories, and this new drug has proved supreme in the protection and treatment of all those working in malarious areas. Paludrine is protecting our soldiers of the Commonwealth Division in Korea. It was also used the conquerors of Everest: Paludrine is only one of the discoveries of world significance which have accrued from ICIs research and development programme a programme to which the company devotes no less than 87,500,000 per year: ICL IMPERIAL CHEMICAL INDUSTRIES (NZ) LTD. by by

This article text was automatically generated and may include errors. View the full page to see article in its original form.I whakaputaina aunoatia ēnei kuputuhi tuhinga, e kitea ai pea ētahi hapa i roto. Tirohia te whārangi katoa kia kitea te āhuatanga taketake o te tuhinga.
Permanent link to this item
Hononga pūmau ki tēnei tūemi

https://paperspast.natlib.govt.nz/periodicals/NZLIST19560921.2.55.2

Bibliographic details
Ngā taipitopito pukapuka

New Zealand Listener, Volume 35, Issue 894, 21 September 1956, Page 25

Word count
Tapeke kupu
145

Page 25 Advertisement 2 New Zealand Listener, Volume 35, Issue 894, 21 September 1956, Page 25

Page 25 Advertisement 2 New Zealand Listener, Volume 35, Issue 894, 21 September 1956, Page 25

Log in or create a Papers Past website account

Use your Papers Past website account to correct newspaper text.

By creating and using this account you agree to our terms of use.

Log in with RealMe®

If you’ve used a RealMe login somewhere else, you can use it here too. If you don’t already have a username and password, just click Log in and you can choose to create one.


Log in again to continue your work

Your session has expired.

Log in again with RealMe®


Alert